论文信息 - Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial - 字舞流文

Evolution of blood-associated HIV-1 DNA levels after 48 weeks of switching to atazanavir/ritonavir+lamivudine dual therapy versus continuing triple therapy in the randomized AtLaS-M trial

G. d’Ettorre | A. De Luca | S. Di Giambenedetto | M. Fabbiani | R. Cauda | A. Castagna | E. Quiros-Roldan | A. Latini | F. Lombardi | R. Gagliardini | S. Belmonti